These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187 [TBL] [Abstract][Full Text] [Related]
25. The podocyte: a potential therapeutic target in diabetic nephropathy? Marshall SM Curr Pharm Des; 2007; 13(26):2713-20. PubMed ID: 17897015 [TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Ziyadeh FN; Wolf G Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694 [TBL] [Abstract][Full Text] [Related]
27. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580 [TBL] [Abstract][Full Text] [Related]
28. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310 [TBL] [Abstract][Full Text] [Related]
30. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117 [TBL] [Abstract][Full Text] [Related]
31. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental. Nasrallah R; Robertson SJ; Karsh J; Hébert RL Clin Sci (Lond); 2013 Jun; 124(11):685-94. PubMed ID: 23305077 [TBL] [Abstract][Full Text] [Related]
32. Distribution of integrin subunits in human diabetic kidneys. Jin DK; Fish AJ; Wayner EA; Mauer M; Setty S; Tsilibary E; Kim Y J Am Soc Nephrol; 1996 Dec; 7(12):2636-45. PubMed ID: 8989742 [TBL] [Abstract][Full Text] [Related]
33. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184 [TBL] [Abstract][Full Text] [Related]
34. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy. Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771 [TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Wolf G; Ziyadeh FN Nephron Physiol; 2007; 106(2):p26-31. PubMed ID: 17570945 [TBL] [Abstract][Full Text] [Related]
36. Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin-selective antagonist. Koh KH; Cao Y; Mangos S; Tardi NJ; Dande RR; Lee HW; Samelko B; Altintas MM; Schmitz VP; Lee H; Mukherjee K; Peev V; Cimbaluk DJ; Reiser J; Hahm E J Clin Invest; 2019 Apr; 129(4):1713-1726. PubMed ID: 30747722 [TBL] [Abstract][Full Text] [Related]
37. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385 [TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188 [TBL] [Abstract][Full Text] [Related]
39. Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo. Gui D; Wei L; Jian G; Guo Y; Yang J; Wang N Cell Physiol Biochem; 2014; 34(6):1849-62. PubMed ID: 25503068 [TBL] [Abstract][Full Text] [Related]
40. Nanostructural features of diabetic podocytopathy. Mandache E; Penescu M Rom J Morphol Embryol; 2012; 53(1):23-7. PubMed ID: 22395495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]